Company Filing History:
17 out of 25 
12 out of 18 
11 out of 843 
Years Active: 2002-2023
Title: Alex J Harvey: Innovator Extraordinaire in Lysosomal Storage Disease Enzymes
Introduction:
Meet Alex J Harvey, an exceptional inventor and patent holder hailing from Athens, Georgia, USA. With an impressive repertoire of 36 patents, Harvey has made significant contributions in the field of lysosomal storage disease enzymes. This article delves into his latest patents, career highlights, notable collaborations, and sheds light on the remarkable innovation journey of this brilliant mind.
Latest Patents:
One of Harvey's recent patents involves the development of compositions of recombinant human lysosomal acid lipase designed for internalization into target cells. By applying particular glycosylation patterns, Harvey has created a methodology that enables the treatment of conditions associated with lysosomal acid lipase deficiency. This breakthrough has the potential to revolutionize treatment strategies for patients with such diseases.
Career Highlights:
During his illustrious career, Harvey has exhibited an unwavering commitment to advancing medical knowledge and improving patient outcomes. His work spans across several influential companies, including Synageva Biopharma Corporation and Avigenics, Inc. (which was initially spelled "AVIGEN INC" before it changed its name). These organizations provided him with unique opportunities to delve deep into research and development, leading to many breakthroughs in his field.
Collaborations:
Throughout his career, Harvey has collaborated with esteemed colleagues who have shared his passion for innovation and scientific excellence. Notable among his coworkers are Jeffrey C Rapp and Robert D Ivarie, who have brought their expertise and dedication to their collaborative efforts. Together, they have contributed significantly to the development of groundbreaking therapies and advancements in lysosomal storage disease enzymes.
Conclusion:
Alex J Harvey is a visionary inventor whose contributions have greatly advanced the understanding and treatment of lysosomal storage diseases. His impressive portfolio of 36 patents, coupled with his career highlights at Synageva Biopharma Corporation and Avigenics, Inc., truly showcases his intellectual prowess and dedication to the field. Collaborations with skilled colleagues like Jeffrey C Rapp and Robert D Ivarie have further reinforced his impact on the industry. As we anticipate Harvey's future endeavors, we can be assured that he will continue to push the boundaries of innovation, ultimately improving the lives of countless patients worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.